161 related articles for article (PubMed ID: 1356117)
1. Effects of budesonide and bambuterol on circadian variation of airway responsiveness and nocturnal symptoms of asthma.
Wempe JB; Tammeling EP; Postma DS; Auffarth B; Teengs JP; Koëter GH
J Allergy Clin Immunol; 1992 Sep; 90(3 Pt 1):349-57. PubMed ID: 1356117
[TBL] [Abstract][Full Text] [Related]
2. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
3. Blood eosinophil numbers and activity during 24 hours: effects of treatment with budesonide and bambuterol.
Wempe JB; Tammeling EP; Koëter GH; Håkansson L; Venge P; Postma DS
J Allergy Clin Immunol; 1992 Nov; 90(5):757-65. PubMed ID: 1430701
[TBL] [Abstract][Full Text] [Related]
4. Effect of regular terbutaline on the airway response to inhaled budesonide.
Wilding PJ; Clark MM; Oborne J; Bennett JA; Tattersfield AE
Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598
[TBL] [Abstract][Full Text] [Related]
5. Effects of inhaled budesonide on the relationships between symptoms, lung function indices and airway hyperresponsiveness in patients with allergic asthma.
Molema J; van Herwaarden CL; Folgering HT
Pulm Pharmacol; 1989; 1(4):179-85. PubMed ID: 2520343
[TBL] [Abstract][Full Text] [Related]
6. Bambuterol: effective in nocturnal asthma.
Petrie GR; Chookang JY; Hassan WU; Morrison JF; O'Reilly JF; Pearson SB; Shneerson JM; Tang OT; Ning AC; Turbitt ML
Respir Med; 1993 Nov; 87(8):581-5. PubMed ID: 8290741
[TBL] [Abstract][Full Text] [Related]
7. Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow.
Waalkens HJ; Gerritsen J; Koëter GH; Krouwels FH; van Aalderen WM; Knol K
Thorax; 1991 Jul; 46(7):499-503. PubMed ID: 1877037
[TBL] [Abstract][Full Text] [Related]
8. The effect of inhaled budesonide on the diurnal variation in airway mechanics, airway responsiveness and serum neutrophil chemotactic activity in Asian patients with predominant nocturnal asthma.
Tan WC; Koh TH; Hay CS; Taylor E
Respirology; 1998 Mar; 3(1):13-20. PubMed ID: 9657654
[TBL] [Abstract][Full Text] [Related]
9. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma.
Haahtela T; Järvinen M; Kava T; Kiviranta K; Koskinen S; Lehtonen K; Nikander K; Persson T; Reinikainen K; Selroos O
N Engl J Med; 1991 Aug; 325(6):388-92. PubMed ID: 2062329
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy, tolerability and patient acceptability of once-daily bambuterol tablets against twice-daily controlled release salbutamol in nocturnal asthma. ACROBATICS Research Group.
Gunn SD; Ayres JG; McConchie SM
Eur J Clin Pharmacol; 1995; 48(1):23-8. PubMed ID: 7621843
[TBL] [Abstract][Full Text] [Related]
12. One month treatment with the once daily oral beta 2-agonist bambuterol in asthmatic patients.
Persson G; Baas A; Knight A; Larsen B; Olsson H
Eur Respir J; 1995 Jan; 8(1):34-9. PubMed ID: 7744191
[TBL] [Abstract][Full Text] [Related]
13. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.
Kraan J; Koëter GH; vd Mark TW; Sluiter HJ; de Vries K
J Allergy Clin Immunol; 1985 Oct; 76(4):628-36. PubMed ID: 4056250
[TBL] [Abstract][Full Text] [Related]
14. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.
Haahtela T; Järvinen M; Kava T; Kiviranta K; Koskinen S; Lehtonen K; Nikander K; Persson T; Selroos O; Sovijärvi A
N Engl J Med; 1994 Sep; 331(11):700-5. PubMed ID: 8058076
[TBL] [Abstract][Full Text] [Related]
15. Use of a fixed combination beta 2-agonist and steroid dry powder inhaler in asthma.
Barnes PJ; O'Connor BJ
Am J Respir Crit Care Med; 1995 Apr; 151(4):1053-7. PubMed ID: 7697230
[TBL] [Abstract][Full Text] [Related]
16. Separate and combined effects of corticosteroids and bronchodilators on airflow obstruction and airway hyperresponsiveness in asthma.
Wempe JB; Postma DS; Breederveld N; Alting-Hebing D; van der Mark TW; Koëter GH
J Allergy Clin Immunol; 1992 Mar; 89(3):679-87. PubMed ID: 1531994
[TBL] [Abstract][Full Text] [Related]
17. Bambuterol in the treatment of asthma. A placebo-controlled comparison of once-daily morning vs evening administration.
D'Alonzo GE; Smolensky MH; Feldman S; Gnosspelius Y; Karlsson K
Chest; 1995 Feb; 107(2):406-12. PubMed ID: 7842769
[TBL] [Abstract][Full Text] [Related]
18. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
Aldridge RE; Hancox RJ; Robin Taylor D; Cowan JO; Winn MC; Frampton CM; Town GI
Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
[TBL] [Abstract][Full Text] [Related]
19. Comparative study using oral solutions of bambuterol once daily or terbutaline three times daily in 2-5-year-old children with asthma. Bambuterol Multicentre Study Group.
Kuusela AL; Marenk M; Sandahl G; Sanderud J; Nikolajev K; Persson B
Pediatr Pulmonol; 2000 Mar; 29(3):194-201. PubMed ID: 10686040
[TBL] [Abstract][Full Text] [Related]
20. Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Dutch CNSLD Study Group.
van Essen-Zandvliet EE; Hughes MD; Waalkens HJ; Duiverman EJ; Kerrebijn KF
Eur Respir J; 1994 Jan; 7(1):63-8. PubMed ID: 7908268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
